GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (OTCPK:ONWRF) » Definitions » Short Interest

Onward Medical NV (Onward Medical NV) Short Interest


View and export this data going back to 2022. Start your Free Trial

What is Onward Medical NV Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Onward Medical NV's Short Interest

For the Biotechnology subindustry, Onward Medical NV's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Short Interest distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Short Interest falls into.


Onward Medical NV (Onward Medical NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (OTCPK:ONWRF) » Definitions » Short Interest
Comparable Companies
XBRU:ALIMG XBRU:CYAD XBRU:BIOS XBRU:OXUR XBRU:HYL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
63E:Germany ONWD:Belgium
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Website
https://www.onwd.com
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (Onward Medical NV) Headlines

No Headlines